| P2093 | author name string | Wei Yang | |
| | Zhikui Liu | |
| | Bowen Yao | |
| | Shaoshan Han | |
| | Kangsheng Tu | |
| P2860 | cites work | PI3K/Akt signalling pathway and cancer. | Q35692250 |
| | miR-93 promotes cell proliferation in gliomas through activation of PI3K/Akt signaling pathway | Q35781570 |
| | Diagnosis and staging of hepatocellular carcinoma | Q35929151 |
| | MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1. | Q35955257 |
| | Growth inhibition by miR-519 via multiple p21-inducing pathways | Q36210880 |
| | miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels | Q37068662 |
| | Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery | Q37089909 |
| | Design and endpoints of clinical trials in hepatocellular carcinoma. | Q37162908 |
| | MicroRNAs in early vertebrate development. | Q37624376 |
| | MicroRNA-92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7. | Q38839341 |
| | MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase | Q38995250 |
| | MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity | Q39893180 |
| | miR-519 suppresses tumor growth by reducing HuR levels | Q41764008 |
| | Impact of PTEN expression on the outcome of hepatitis C virus-positive cirrhotic hepatocellular carcinoma patients: possible relationship with COX II and inducible nitric oxide synthase | Q43038834 |
| | The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression | Q44557868 |
| | MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway | Q47616223 |
| | Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221 | Q24631381 |
| | The PI3K pathway as drug target in human cancer | Q24632283 |
| | MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 |
| | MicroRNA expression profiles classify human cancers | Q28032481 |
| | Switching from repression to activation: microRNAs can up-regulate translation | Q28131790 |
| | Hepatocellular carcinoma: epidemiology and molecular carcinogenesis | Q28306363 |
| | The functions and regulation of the PTEN tumour suppressor | Q29615536 |
| | MicroRNAs in Cancer | Q29615539 |
| | New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway | Q29616144 |
| | miRNAs, cancer, and stem cell division | Q29618925 |
| | Primary liver cancer: worldwide incidence and trends | Q29620133 |
| | PTEN gene and integrin signaling in cancer | Q33765703 |
| | MicroRNA profiling in human diploid fibroblasts uncovers miR-519 role in replicative senescence | Q34056462 |
| | Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours | Q34150301 |
| | MicroRNA-130b promotes cell aggressiveness by inhibiting peroxisome proliferator-activated receptor gamma in human hepatocellular carcinoma | Q34685429 |
| | MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer | Q34984068 |
| P433 | issue | 3 | |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 965-974 | |
| P577 | publication date | 2015-12-28 | |
| P1433 | published in | International Journal of Oncology | Q6051527 |
| P1476 | title | MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma | |
| P478 | volume | 48 | |